Compare · APDN vs RTO
APDN vs RTO
Side-by-side comparison of Applied DNA Sciences Inc. (APDN) and Rentokil Initial plc (RTO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both APDN and RTO operate in Other Consumer Services (Consumer Discretionary), so they compete in similar markets.
- RTO is the larger of the two at $7.50B, about 313.2x APDN ($24.0M).
- Over the past year, APDN is up 2.5% and RTO is up 25.3% - RTO leads by 22.7 points.
- RTO has hit the wire 2 times in the past 4 weeks while APDN has been quiet.
- RTO has more recent analyst coverage (12 ratings vs 2 for APDN).
- Company
- Applied DNA Sciences Inc.
- Rentokil Initial plc
- Price
- $5.67+31.25%
- $29.74+2.11%
- Market cap
- $24.0M
- $7.50B
- 1M return
- +142.31%
- -12.01%
- 1Y return
- +2.53%
- +25.27%
- Industry
- Other Consumer Services
- Other Consumer Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2022
- News (4w)
- 0
- 2
- Recent ratings
- 2
- 12
Applied DNA Sciences Inc.
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes applications in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications and can be used to fortify brand protection efforts, and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide definitive real-time authentication of molecular tags in the field; and CertainT Supply Chain Platform that provides proof of product claims for materials, items, or products. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and non-diagnostic COVID-19 pooled surveillance testing to detect instances of COVID-19 in defined populations under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
Latest APDN
- SEC Form DEFA14A filed by Applied DNA Sciences Inc.
- Applied DNA Sciences Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
- Amendment: SEC Form SCHEDULE 13G/A filed by Applied DNA Sciences Inc.
- Applied DNA Sciences Inc. filed SEC Form 8-K: Leadership Update
- SEC Form DEF 14A filed by Applied DNA Sciences Inc.
- SEC Form 424B5 filed by Applied DNA Sciences Inc.
- Applied DNA Sciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- SEC Form PRE 14A filed by Applied DNA Sciences Inc.
- SEC Form S-1 filed by Applied DNA Sciences Inc.
- Applied DNA Sciences Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
Latest RTO
- SEC Form SD filed by Rentokil Initial plc
- SEC Form 6-K filed by Rentokil Initial plc
- SEC Form 6-K filed by Rentokil Initial plc
- SEC Form 6-K filed by Rentokil Initial plc
- Terminix Debuts New Podcast to Help Businesses Mitigate Operational Risk
- SEC Form 6-K filed by Rentokil Initial plc
- SEC Form 6-K filed by Rentokil Initial plc
- New York City Replaces Los Angeles as America's Most Mosquito‑Infested City, New Terminix Data Reveals
- SEC Form 6-K filed by Rentokil Initial plc
- SEC Form 6-K filed by Rentokil Initial plc